-+ 0.00%
-+ 0.00%
-+ 0.00%

Quanex Building Products (NX) Stock May Still Be Cheap After A 42% Run

Simply Wall St·09/11/2026 12:27:22
Listen to the news

Quanex Building Products has delivered a strong 41.6% return over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to the stock trading below what its cash flows may justify. With several valuation checks flagging upside while the recent share price move reshapes expectations, the stock now sits in a space where value and performance are pulling in the same direction, but only up to a point.

  • The 41.6% gain over 1 year puts Quanex Building Products among the stronger performers in its peer group, which raises the bar for what counts as a meaningful margin of safety from here.
  • Stronger and more predictable cash generation can support the current pricing, while any pressure on construction activity or building product demand may quickly feed through to the valuation case.
  • The broader checks show a mixed picture rather than a clear bargain or clear overvaluation, with the company scoring 4 out of 6 on value tests and both the intrinsic value estimate and earnings multiples pointing to undervaluation.

The issue now is whether Quanex Building Products still offers enough valuation upside after this run to appeal to investors who are focused on price paid versus underlying cash flows.

Scan beyond Quanex Building Products to compare its setup with 33 high quality undervalued stocks that combine strong cash generation with valuations the market has not fully priced in yet.

Is Quanex Building Products a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here is built around Quanex Building Products’ ability to convert its operations into steady free cash. On the latest figures, the business generated about $88 million of free cash flow over the last twelve months, and the projections assume modest, largely stable cash generation rather than aggressive expansion or sharp decline.

On those inputs, the DCF model points to an estimated intrinsic value of about $24.28 per share. Compared with the current market price, that implies the stock trades at roughly a 13.2% discount to the cash flows underpinning Quanex Building Products today. The gap is not huge, yet it suggests the recent share price strength has not fully erased the valuation cushion that cash flow focused investors often look for.

On this cash flow view, Quanex Building Products stock still screens as undervalued relative to its estimated intrinsic worth.

Our Discounted Cash Flow (DCF) analysis suggests Quanex Building Products is undervalued by 13.2%. Track this in your watchlist or portfolio, or discover 33 more high quality undervalued stocks.

NX Discounted Cash Flow as at Sep 2026
NX Discounted Cash Flow as at Sep 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Quanex Building Products.

Does Quanex Building Products Look Undervalued on Earnings?

The P/E ratio works well for Quanex Building Products because earnings are a key output of its cash generation story. On this yardstick, the shares trade at about 21.1x earnings, which is slightly above the building industry average of roughly 20.8x and comfortably above the peer group average near 15.7x. Taken in isolation, that kind of premium to peers might look like investors are already paying up for the ticker.

The fair P/E ratio from the model sits higher, at about 26.1x. That is the level implied by Quanex Building Products’ own mix of profitability, size and risk, rather than a simple sector average. The current multiple is therefore below this tailored fair value marker, which indicates the market is not fully pricing in what the earnings base could justify on this framework.

On the P/E approach, Quanex Building Products stock appears undervalued relative to the level implied by its earnings profile.

NYSE:NX P/E Ratio as at Sep 2026
NYSE:NX P/E Ratio as at Sep 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Quanex Building Products Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Quanex Building Products valuation puzzle leaves off. They spell out which expectations for Quanex Building Products' future cash generation, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price, and each one treats fair value as a thesis about the business that you can watch play out over time rather than as a one off snapshot.

One of the top community narratives on Quanex Building Products: 37% undervalued

"Quanex is the consolidated share leader in fenestration components and the only supplier offering hardware, extrusions, spacers, and seals as a bundled package to window OEMs, creating spec-in switching costs that support 90%+ retention on qualified programs..."

Read one of the top narratives on Quanex Building Products

Do you think there's more to the story for Quanex Building Products? Head over to our Community to see what others are saying!

The Bottom Line

Quanex Building Products screens as undervalued on both the Discounted Cash Flow (DCF) intrinsic estimate and its earnings multiple, although neither signal is extreme. The valuation gap now hinges less on models and more on whether free cash flow and margins can hold up against any cooling in construction and building product demand. If those cash flows prove resilient, the current discount could look conservative. If end market activity softens or pricing power weakens, the current tag may reflect a fair caution rather than a mispricing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.